Podcast


Presenter: Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD

In episode 572, James and Mike invite Samantha Moe back to the podcast to go over the evidence around the safety and effectiveness of the monoclonal antibodies used to reduce the risk of respiratory syncytial virus (RSV) infections in infants. We go over all the numbers for hospitalizations and death so you can make evidence-informed…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here



CFPCLearn Logo

Listening to the Podcast can earn you MainPro+ Credits

Join Now

Already a CFPCLearn Member? Log in



Latest Podcasts

In the Clinic Episode #40: Heart failure follow up

In this episode of In the Clinic, Mike and Jess invite back Dr. Dr. Emelie Braschi.  The team discusses Mr. Ramakanta, a 75 year old male with reduced ejection fraction…
Listen 0.5 credits available

In the Clinic Episode #39: Heart failure

In this episode of In the Clinic, Mike and Jess invite back Dr. Emelie Braschi. The team discusses Mr. Ramakanta, a 75 year old male recently discharged from the hospital…
Listen 0.5 credits available

In the Clinic Episode #38: Pediatric asthma exacerbation

In this episode of In the Clinic, Mike and Jess invite back Dr. Jennifer Young.  The team discusses Brea Salter, a 4 year old female with a  two day history…
Listen 0.5 credits available

Presenter(s):

Dr. James McCormack Dr. Mike Allan Samantha Moe PharmD

This content is certified for MainPro+ Credits, log in to access


Presenter(s):

  • Dr. James McCormack
  • Dr. Mike Allan
  • Samantha Moe PharmD

Spearkers do not have any conflicts of interest to declare.